Employee Stories
Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company
About Us
Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.
First Subject Enrolled in Phase Ⅱ Clinical Trial of Luye Pharma’s TAAR1/5-HT2CR-targeted Investigational Drug for Treating Schizophrenia
News
Shanghai, April 8th, 2026 – Luye Pharma Group today announced that the first subject has been enrolled in a Phase Ⅱ clinical trial in China evaluating its LY03020 for the treatment of schizophrenia. Filed through China’s Class 1 ...
April 08,2026
Luye Pharma Announces 2025 Financial Results
- New product sales up 56.8% - - Net profit attributable to parent company up 31.1% - Shanghai, March 31, 2026 -- Luye Pharma Group (2186.HK) today announced its annual results for fiscal year 2025 and the latest developments. In the ...
April 01,2026
Investors
New Year, New Team, New Power
Interview with Employees of Luye Pharma UK and Functional Team Members
A Dream of Thirteen Years
Interview with Project Team Members of LY01005
Historic Breakthrough, Brand New Journey
The Story of Rykindo® (LY03004) Approval in the U.S.
My Three Years with Luye US
Antonia Sacchetti
Office Manager, Luye Pharma (US)
Learn the Best of the People around You
Yan Yameng
HR BP, Luye Pharma
To Practice with Every Opportunity
Wang Chao
Director of Engineering Department II, Shandong Luye
